{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["5(1)"],"submitter":["Segawa T"],"pubmed_abstract":["<h4>Aims</h4>This study aimed to investigate the relationship between corticosteroid therapy and long-term outcomes in patients with cardiac sarcoidosis, stratified by left ventricular ejection fraction (LVEF) at diagnosis.<h4>Methods and results</h4>This study conducted a <i>post hoc</i> analysis of the ILLUstration of the Management and prognosIs of JapaNese PATiEnts with Cardiac Sarcoidosis, a retrospective multicentre registry. Cardiac sarcoidosis was diagnosed based on the 2016 Japanese Circulation Society and 2014 Heart Rhythm Society criteria. The primary endpoint was a composite of all-cause death, hospitalization for heart failure, and fatal ventricular arrhythmia events. Patients were divided into three groups based on LVEF: preserved LVEF (≥50%, <i>n</i> = 251), moderately impai"],"journal":["European heart journal open"],"pagination":["oeae100"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11720171"],"repository":["biostudies-literature"],"pubmed_title":["Corticosteroid therapy and long-term outcomes in patients with cardiac sarcoidosis stratified by left ventricular ejection fraction."],"pmcid":["PMC11720171"],"pubmed_authors":["Segawa T","Kitai T","Tanaka H","Baba Y","Naruse Y","Matsue Y","Sakata Y","Taniguchi T","Yoshioka K","Nabeta T","Okumura T"],"additional_accession":[]},"is_claimable":false,"name":"Corticosteroid therapy and long-term outcomes in patients with cardiac sarcoidosis stratified by left ventricular ejection fraction.","description":"<h4>Aims</h4>This study aimed to investigate the relationship between corticosteroid therapy and long-term outcomes in patients with cardiac sarcoidosis, stratified by left ventricular ejection fraction (LVEF) at diagnosis.<h4>Methods and results</h4>This study conducted a <i>post hoc</i> analysis of the ILLUstration of the Management and prognosIs of JapaNese PATiEnts with Cardiac Sarcoidosis, a retrospective multicentre registry. Cardiac sarcoidosis was diagnosed based on the 2016 Japanese Circulation Society and 2014 Heart Rhythm Society criteria. The primary endpoint was a composite of all-cause death, hospitalization for heart failure, and fatal ventricular arrhythmia events. Patients were divided into three groups based on LVEF: preserved LVEF (≥50%, <i>n</i> = 251), moderately impai","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Jan","modification":"2025-04-04T03:06:01.382Z","creation":"2025-04-04T03:06:01.382Z"},"accession":"S-EPMC11720171","cross_references":{"pubmed":["39801602"],"doi":["10.1093/ehjopen/oeae100"]}}